A Bioavailability Study of LY2452473 and Tadalafil

NCT01401543 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Erectile Dysfunction

Interventions

DRUG: LY2452473
DRUG: Tadalafil
DRUG: LY900010

Sponsor

Eli Lilly and Company